The 1 analysts offering 12-month price forecasts for Applied Therapeutics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +563.51% increase from the last price of 2.11.
The current consensus among 1 polled investment analysts is to Outperform stock in Applied Therapeutics Inc. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.27
Reporting Date Mar 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.